Log In
BCIQ
Print this Print this
 

biosimilar etanercept (BAX 2200, CHS-0214)

  Manage Alerts
Collapse Summary General Information
Company Coherus BioSciences Inc.
DescriptionBiosimilar of etanercept, a recombinant p75 tumor necrosis factor (TNF) receptor linked to the Fc portion of human IgG1 (TNFr:Fc)
Molecular Target Tumor necrosis factor (TNF) alpha ; Lymphotoxin alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Antibody; Biosimilar
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$276.0M

$40.0M

$216.0M


 Deals Details
Get a free BioCentury trial today